Data-poor categorization and passage retrieval for Gene Ontology Annotation in Swiss-Prot

por Ehrler, Frédéric, Geissbühler, Antoine, Jimeno, Antonio, Ruch, Patrick
Publicado 2005

Assessment of disease named entity recognition on a corpus of annotated sentences

por Jimeno, Antonio, Jimenez-Ruiz, Ernesto, Lee, Vivian, Gaudan, Sylvain, Berlanga, Rafael, Rebholz-Schuhmann, Dietrich
Publicado 2008

ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways

por Singh, Surendra, Arcaroli, John, Chen, Ying, Thompson, David C., Messersmith, Wells, Jimeno, Antonio, Vasiliou, Vasilis
Publicado 2015

Generation of functional thymic organoids from human pluripotent stem cells

por Ramos, Stephan A., Armitage, Lucas H., Morton, John J., Alzofon, Nathaniel, Handler, Diana, Kelly, Geoffrey, Homann, Dirk, Jimeno, Antonio, Russ, Holger A.
Publicado 2023

Expansion of Human and Murine Hematopoietic Stem and Progenitor Cells Ex Vivo without Genetic Modification Using MYC and Bcl-2 Fusion Proteins

por Bird, Gregory A., Polsky, Avital, Estes, Patricia, Hanlon, Teri, Hamilton, Haley, Morton, John J., Gutman, Jonathan, Jimeno, Antonio, Turner, Brian C., Refaeli, Yosef
Publicado 2014

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance

por Amini, Arya, McDermott, Jessica D., Gan, Gregory, Bhatia, Shilpa, Sumner, Whitney, Fisher, Christine M., Jimeno, Antonio, Bowles, Daniel W., Raben, David, Karam, Sana D.
Publicado 2014

Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma

por Strait, Alexander A., Woolaver, Rachel A., Hall, Spencer C., Young, Christian D., Karam, Sana D., Jimeno, Antonio, Lan, Yan, Raben, David, Wang, Jing H., Wang, Xiao-Jing
Publicado 2021

Phase 1 Study of ABT‐751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer

por Rudek, Michelle A., Dasari, Arvind, Laheru, Daniel, He, Ping, Jin, Runyan, Walker, Rosalind, Taylor, Gretchen E., Jimeno, Antonio, Donehower, Ross C., Hidalgo, Manuel, Messersmith, Wells A., Purcell, W. Thomas
Publicado 2016

Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas

por Bhatia, Shilpa, Hirsch, Kellen, Sharma, Jaspreet, Oweida, Ayman, Griego, Anastacia, Keysar, Stephen, Jimeno, Antonio, Raben, David, Krasnoperov, Valery, Gill, Parkash S., Pasquale, Elena B., Wang, Xiao-Jing, Karam, Sana D.
Publicado 2016

An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases

por Kleczko, Emily K., Kim, Jihye, Keysar, Stephen B., Heasley, Lydia R., Eagles, Justin R., Simon, Matthew, Marshall, Marianne E., Singleton, Katherine R., Jimeno, Antonio, Tan, Aik-Choon, Heasley, Lynn E.
Publicado 2015

DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E(2) Growth Factor Release in Response to Low and High LET Ionizing Radiation

por Allen, Christopher P., Tinganelli, Walter, Sharma, Neelam, Nie, Jingyi, Sicard, Cory, Natale, Francesco, King, Maurice, Keysar, Steven B., Jimeno, Antonio, Furusawa, Yoshiya, Okayasu, Ryuichi, Fujimori, Akira, Durante, Marco, Nickoloff, Jac A.
Publicado 2015

Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts

por Woolaver, Rachel A, Wang, Xiaoguang, Krinsky, Alexandra L, Waschke, Brittany C, Chen, Samantha M Y, Popolizio, Vince, Nicklawsky, Andrew G, Gao, Dexiang, Chen, Zhangguo, Jimeno, Antonio, Wang, Xiao-Jing, Wang, Jing Hong
Publicado 2021

MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma

por Berggren, Kiersten L., Cruz, Sebastian Restrepo, Hixon, Michael D, Cowan, Andrew, Keysar, Stephen B., Craig, Stephanie, James, Jacqueline, Barry, Marc, Ozbun, Michelle A., Jimeno, Antonio, McCance, Dennis J., Beswick, Ellen J., Gan, Gregory N.
Publicado 2019

Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study

por Taylor, Matthew H., Betts, Courtney B., Maloney, Lauren, Nadler, Eric, Algazi, Alain, Guarino, Michael J., Nemunaitis, John, Jimeno, Antonio, Patel, Priti, Munugalavadla, Veerendra, Tao, Lin, Adkins, Douglas, Goldschmidt, Jerome H., Cohen, Ezra E.W., Coussens, Lisa M.
Publicado 2022

The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma

por Nieto, Cera, Miller, Bettina, Alzofon, Nathaniel, Chimed, Tugy, Himes, Jack, Joshi, Molishree, Gomez, Karina, Chowdhury, Farshad N, Le, Phuong N, Weaver, Alice, Somerset, Hilary, Morton, J Jason, Wang, Jing H, Wang, Xiao-Jing, Gao, Dexiang, Hansen, Kirk, Keysar, Stephen B, Jimeno, Antonio
Publicado 2023

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

por Fayette, Jérôme, Wirth, Lori, Oprean, Cristina, Udrea, Anghel, Jimeno, Antonio, Rischin, Danny, Nutting, Christopher, Harari, Paul M., Csoszi, Tibor, Cernea, Dana, O’Brien, Paul, Hanley, William D., Kapp, Amy V., Anderson, Maria, Penuel, Elicia, McCall, Bruce, Pirzkall, Andrea, Vermorken, Jan B.
Publicado 2016

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

por Siu, Lillian, Brody, Joshua, Gupta, Shilpa, Marabelle, Aurélien, Jimeno, Antonio, Munster, Pamela, Grilley-Olson, Juneko, Rook, Alain H, Hollebecque, Antoine, Wong, Rebecca K S, Welsh, James W, Wu, Yuling, Morehouse, Christopher, Hamid, Oday, Walcott, Farzana, Cooper, Zachary A, Kumar, Rakesh, Ferté, Charles, Hong, David S
Publicado 2020

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy

por Huang, Qian, Li, Fang, Liu, Xinjian, Li, Wenrong, Shi, Wei, Liu, Fei-Fei, O’Sullivan, Brian, He, Zhimin, Peng, Yuanlin, Tan, Aik-Choon, Zhou, Ling, Shen, Jingping, Han, Gangwen, Wang, Xiao-Jing, Thorburn, Jackie, Thorburn, Andrew, Jimeno, Antonio, Raben, David, Bedford, Joel S., Li, Chuan-Yuan
Publicado 2011

Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors

por Jimeno, Antonio, Baranda, Joaquina, Iams, Wade T., Park, Jong Chul, Mita, Monica, Gordon, Michael S., Taylor, Matthew, Dhani, Neesha, Leal, Alexis D., Neupane, Prakash, Eng, Cathy, Yeku, Oladapo, Mita, Alain, Moser, Justin C., Butler, Marcus, Loughhead, Scott M., Jennings, Julia, Miselis, Nathan R., Ji, Rui-Ru, Nair, Nitya, Kornacker, Martin, Zwirtes, Ricardo F., Bernstein, Howard, Sharei, Armon
Publicado 2023

Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer

por Bouhaddou, Mehdi, Lee, Rex H., Li, Hua, Bhola, Neil E., O’Keefe, Rachel A., Naser, Mohammad, Zhu, Tian Ran, Nwachuku, Kelechi, Duvvuri, Umamaheswar, Olshen, Adam B., Roy, Ritu, Hechmer, Aaron, Bolen, Jennifer, Keysar, Stephen B., Jimeno, Antonio, Mills, Gordon B., Vandenberg, Scott, Swaney, Danielle L., Johnson, Daniel E., Krogan, Nevan J., Grandis, Jennifer R.
Publicado 2021